( June 26, 2025, 2:19 PM EDT) -- NEW ORLEANS — Two e-liquid companies who partly lost their challenge to a Food and Drug Administration ban of their products before the U.S. Supreme Court on June 25 filed a letter with the Fifth Circuit U.S. Court of Appeals asking that the en banc court hear new arguments on surviving issues remanded by the high court, specifically whether FDA followed proper rulemaking procedures and whether it erred harmlessly by ignoring the companies’ marketing plan....